CD4 and COVID-19: Moreover, we identified that the extent of increase in PCGrimAge estimates for participants following COVID-19 was significantly related to blood immune cell compositional changes in CD4 T cells, NK cells, B cells, granulocytes, and plasmablasts (Figure 5).